Lantern Wealth Advisors’s MediciNova MNOV Stock Holding History

Lantern Wealth Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$39.3K	–	181
2025 Q4	$39.3K	Buy	+30,000	New	+$41.4K	0.02%	163

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Lantern Wealth Advisors's MNOV Position: Q1 2026 in Review

Lantern Wealth Advisors sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 30,000 shares — an estimated $39.3K sold.

Lantern Wealth Advisors first reported a position in MNOV in Q4 2025 and held it in 1 quarter. The position peaked at $39.3K in Q4 2025. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

Lantern Wealth Advisors reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
Lantern Wealth Advisors sold 30,000 MediciNova shares in Q1 2026, an estimated $39.3K.
Lantern Wealth Advisors first reported a position in MediciNova in Q4 2025 and held it in 1 quarter.
Lantern Wealth Advisors's MediciNova position peaked at $39.3K in Q4 2025.
30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Lantern Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.